O	0	1	A	A	DT	B-NP
O	2	5	key	key	JJ	I-NP
O	6	10	role	role	NN	I-NP
O	11	14	for	for	IN	B-PP
O	15	18	the	the	DT	B-NP
O	19	27	integrin	integrin	NN	I-NP
O	28	39	alpha2beta1	alpha2beta1	NN	I-NP
O	40	42	in	in	IN	B-PP
O	43	55	experimental	experimental	JJ	B-NP
O	56	59	and	and	CC	I-NP
O	60	73	developmental	developmental	JJ	I-NP
O	74	86	angiogenesis	angiogenesis	NN	I-NP
O	86	87	.	.	.	O

O	88	91	The	The	DT	B-NP
O	92	103	alpha2beta1	alpha2beta1	NN	I-NP
O	104	112	integrin	integrin	NN	I-NP
O	113	121	receptor	receptor	NN	I-NP
O	122	127	plays	play	VBZ	B-VP
O	128	129	a	a	DT	B-NP
O	130	133	key	key	JJ	I-NP
O	134	138	role	role	NN	I-NP
O	139	141	in	in	IN	B-PP
O	142	154	angiogenesis	angiogenesis	NN	B-NP
O	154	155	.	.	.	O

O	156	160	Here	Here	RB	B-ADVP
O	161	163	we	we	PRP	B-NP
O	164	176	investigated	investigate	VBD	B-VP
O	177	180	the	the	DT	B-NP
O	181	188	effects	effect	NNS	I-NP
O	189	191	of	of	IN	B-PP
O	192	197	small	small	JJ	B-NP
O	198	206	molecule	molecule	NN	I-NP
O	207	217	inhibitors	inhibitor	NNS	I-NP
O	218	219	(	(	(	O
O	219	223	SMIs	SMI	NNS	B-NP
O	223	224	)	)	)	O
O	225	233	designed	design	VBN	B-VP
O	234	236	to	to	TO	I-VP
O	237	244	disrupt	disrupt	VB	I-VP
O	245	253	integrin	integrin	NN	B-NP
O	254	260	alpha2	alpha2	NN	I-NP
O	261	262	I	I	CD	I-NP
O	263	265	or	or	CC	O
O	266	271	beta1	beta1	NN	B-NP
O	272	273	I	I	CD	I-NP
O	273	274	-	-	HYPH	B-NP
O	274	278	like	like	JJ	I-NP
O	279	285	domain	domain	NN	I-NP
O	286	294	function	function	NN	I-NP
O	295	297	on	on	IN	B-PP
O	298	310	angiogenesis	angiogenesis	NN	B-NP
O	310	311	.	.	.	O

O	312	314	In	In	IN	B-PP
O	315	327	unchallenged	unchallenged	JJ	B-NP
B-Cell	328	339	endothelial	endothelial	JJ	I-NP
I-Cell	340	345	cells	cell	NNS	I-NP
O	345	346	,	,	,	O
B-Cellular_component	347	356	fibrillar	fibrillar	JJ	B-NP
O	357	365	collagen	collagen	NN	I-NP
O	366	373	induced	induce	VBD	B-VP
O	374	380	robust	robust	JJ	B-NP
B-Tissue	381	390	capillary	capillary	JJ	I-NP
O	391	404	morphogenesis	morphogenesis	NN	I-NP
O	404	405	.	.	.	O

O	406	408	In	In	IN	B-PP
O	409	417	contrast	contrast	NN	B-NP
O	417	418	,	,	,	O
B-Tissue	419	423	tube	tube	NN	B-NP
O	424	433	formation	formation	NN	I-NP
O	434	437	was	be	VBD	B-VP
O	438	451	significantly	significantly	RB	I-VP
O	452	459	reduced	reduce	VBN	I-VP
O	460	462	by	by	IN	B-PP
O	463	469	SMI496	SMI496	NN	B-NP
O	469	470	,	,	,	O
O	471	472	a	a	DT	B-NP
O	473	478	beta1	beta1	NN	I-NP
O	479	480	I	I	CD	I-NP
O	480	481	-	-	HYPH	I-NP
O	481	485	like	like	JJ	I-NP
O	486	492	domain	domain	NN	I-NP
O	493	502	inhibitor	inhibitor	NN	I-NP
O	503	506	and	and	CC	B-PP
O	507	509	by	by	IN	B-PP
O	510	518	function	function	NN	B-NP
O	518	519	-	-	HYPH	O
O	519	527	blocking	block	VBG	B-VP
O	528	532	anti	anti	AFX	B-NP
O	532	533	-	-	HYPH	I-NP
O	533	544	alpha2beta1	alpha2beta1	NN	I-NP
O	545	548	but	but	CC	B-CONJP
O	549	552	not	not	RB	I-CONJP
O	553	554	-	-	HYPH	B-ADVP
O	554	565	alpha1beta1	alpha1beta1	NN	B-NP
O	566	576	antibodies	antibody	NNS	I-NP
O	576	577	.	.	.	O

B-Cell	578	589	Endothelial	Endothelial	JJ	B-NP
I-Cell	590	595	cells	cell	NNS	I-NP
O	596	601	bound	bind	VBD	B-VP
O	602	613	fluorescein	fluorescein	NN	B-NP
O	613	614	-	-	HYPH	O
O	614	621	labeled	label	VBN	B-VP
O	622	630	collagen	collagen	NN	B-NP
O	631	632	I	I	CD	I-NP
B-Cellular_component	633	640	fibrils	fibril	NNS	I-NP
O	640	641	,	,	,	O
O	642	644	an	an	DT	B-NP
O	645	656	interaction	interaction	NN	I-NP
O	657	669	specifically	specifically	RB	B-VP
O	670	679	inhibited	inhibit	VBN	I-VP
O	680	682	by	by	IN	B-PP
O	683	689	SMI496	SMI496	NN	B-NP
O	689	690	.	.	.	O

O	691	699	Moreover	Moreover	RB	B-ADVP
O	699	700	,	,	,	O
O	701	707	SMI496	SMI496	NN	B-NP
O	708	714	caused	cause	VBD	B-VP
B-Cell	715	719	cell	cell	NN	B-NP
O	720	730	retraction	retraction	NN	I-NP
O	731	734	and	and	CC	O
B-Cellular_component	735	747	cytoskeletal	cytoskeletal	JJ	B-NP
O	748	756	collapse	collapse	NN	I-NP
O	757	759	of	of	IN	B-PP
B-Cell	760	771	endothelial	endothelial	JJ	B-NP
I-Cell	772	777	cells	cell	NNS	I-NP
O	778	780	as	as	RB	B-CONJP
O	781	785	well	well	RB	I-CONJP
O	786	788	as	as	IN	I-CONJP
O	789	796	delayed	delay	VBN	B-NP
B-Cell	797	808	endothelial	endothelial	JJ	I-NP
I-Cell	809	813	cell	cell	NN	I-NP
B-Pathological_formation	814	819	wound	wound	NN	I-NP
O	820	827	healing	healing	NN	I-NP
O	827	828	.	.	.	O

O	829	832	SMI	SMI	NN	B-NP
O	833	843	activities	activity	NNS	I-NP
O	844	848	were	be	VBD	B-VP
O	849	857	examined	examine	VBN	I-VP
O	858	860	in	in	FW	B-ADVP
O	861	865	vivo	vivo	FW	I-ADVP
O	866	868	by	by	IN	B-PP
O	869	882	supplementing	supplement	VBG	B-VP
O	883	886	the	the	DT	B-NP
O	887	893	growth	growth	NN	I-NP
O	894	900	medium	medium	NN	I-NP
O	901	903	of	of	IN	B-PP
O	904	913	zebrafish	zebrafish	NN	B-NP
B-Developing_anatomical_structure	914	921	embryos	embryo	NNS	I-NP
O	922	932	expressing	express	VBG	B-VP
O	933	938	green	green	JJ	B-NP
O	939	950	fluorescent	fluorescent	JJ	I-NP
O	951	958	protein	protein	NN	I-NP
O	959	964	under	under	IN	B-PP
O	965	968	the	the	DT	B-NP
O	969	976	control	control	NN	I-NP
O	977	979	of	of	IN	B-PP
O	980	983	the	the	DT	B-NP
O	984	992	vascular	vascular	JJ	I-NP
O	993	1004	endothelial	endothelial	JJ	I-NP
O	1005	1011	growth	growth	NN	I-NP
O	1012	1018	factor	factor	NN	I-NP
O	1019	1027	receptor	receptor	NN	I-NP
O	1027	1028	-	-	HYPH	B-NP
O	1028	1029	2	2	CD	I-NP
O	1030	1038	promoter	promoter	NN	I-NP
O	1038	1039	.	.	.	O

O	1040	1046	SMI496	SMI496	NN	B-NP
O	1046	1047	,	,	,	O
O	1048	1051	but	but	CC	B-CONJP
O	1052	1055	not	not	RB	I-CONJP
O	1056	1057	a	a	DT	B-NP
O	1058	1065	control	control	NN	I-NP
O	1066	1074	compound	compound	NN	I-NP
O	1074	1075	,	,	,	O
O	1076	1086	interfered	interfere	VBD	B-VP
O	1087	1091	with	with	IN	B-PP
O	1092	1104	angiogenesis	angiogenesis	NN	B-NP
O	1105	1107	in	in	FW	B-ADVP
O	1108	1112	vivo	vivo	FW	I-ADVP
O	1113	1115	by	by	IN	B-PP
O	1116	1126	reversibly	reversibly	RB	B-VP
O	1127	1137	inhibiting	inhibit	VBG	I-VP
O	1138	1147	sprouting	sprout	VBG	I-VP
O	1148	1152	from	from	IN	B-PP
O	1153	1156	the	the	DT	B-NP
B-Multi-tissue_structure	1157	1162	axial	axial	JJ	I-NP
I-Multi-tissue_structure	1163	1170	vessels	vessel	NNS	I-NP
O	1170	1171	.	.	.	O

O	1172	1174	We	We	PRP	B-NP
O	1175	1182	further	further	RB	B-ADVP
O	1183	1196	characterized	characterize	VBD	B-VP
O	1197	1206	zebrafish	zebrafish	NN	B-NP
O	1207	1213	alpha2	alpha2	NN	I-NP
O	1214	1222	integrin	integrin	NN	I-NP
O	1223	1226	and	and	CC	O
O	1227	1237	discovered	discover	VBD	B-VP
O	1238	1242	that	that	IN	B-SBAR
O	1243	1247	this	this	DT	B-NP
O	1248	1256	integrin	integrin	NN	I-NP
O	1257	1259	is	be	VBZ	B-VP
O	1260	1266	highly	highly	RB	I-VP
O	1267	1276	conserved	conserve	VBN	I-VP
O	1276	1277	,	,	,	O
O	1278	1288	especially	especially	RB	B-ADVP
O	1289	1292	the	the	DT	B-NP
O	1293	1294	I	I	NN	I-NP
O	1295	1301	domain	domain	NN	I-NP
O	1301	1302	.	.	.	O

O	1303	1310	Notably	Notably	RB	B-ADVP
O	1310	1311	,	,	,	O
O	1312	1313	a	a	DT	B-NP
O	1314	1321	similar	similar	JJ	I-NP
B-Multi-tissue_structure	1322	1330	vascular	vascular	JJ	I-NP
O	1331	1340	phenotype	phenotype	NN	I-NP
O	1341	1344	was	be	VBD	B-VP
O	1345	1352	induced	induce	VBN	I-VP
O	1353	1355	by	by	IN	B-PP
O	1356	1366	morpholino	morpholino	AFX	B-NP
O	1366	1367	-	-	HYPH	I-NP
O	1367	1375	mediated	mediate	VBN	B-NP
O	1376	1385	knockdown	knockdown	NN	I-NP
O	1386	1388	of	of	IN	B-PP
O	1389	1392	the	the	DT	B-NP
O	1393	1401	integrin	integrin	NN	I-NP
O	1402	1408	alpha2	alpha2	NN	I-NP
O	1409	1416	subunit	subunit	NN	I-NP
O	1416	1417	.	.	.	O

O	1418	1420	By	By	IN	B-PP
O	1421	1425	live	live	JJ	B-NP
O	1426	1441	videomicroscopy	videomicroscopy	NN	I-NP
O	1441	1442	,	,	,	O
O	1443	1445	we	we	PRP	B-NP
O	1446	1455	confirmed	confirm	VBD	B-VP
O	1456	1460	that	that	IN	B-SBAR
O	1461	1464	the	the	DT	B-NP
B-Multi-tissue_structure	1465	1472	vessels	vessel	NNS	I-NP
O	1473	1477	were	be	VBD	B-VP
O	1478	1485	largely	largely	RB	B-ADJP
O	1486	1499	nonfunctional	nonfunctional	JJ	I-ADJP
O	1500	1502	in	in	IN	B-PP
O	1503	1506	the	the	DT	B-NP
O	1507	1514	absence	absence	NN	I-NP
O	1515	1517	of	of	IN	B-PP
O	1518	1529	alpha2beta1	alpha2beta1	NN	B-NP
O	1530	1538	integrin	integrin	NN	I-NP
O	1538	1539	.	.	.	O

O	1540	1552	Collectively	Collectively	RB	B-ADVP
O	1552	1553	,	,	,	O
O	1554	1557	our	our	PRP$	B-NP
O	1558	1565	results	result	NNS	I-NP
O	1566	1573	provide	provide	VBP	B-VP
O	1574	1580	strong	strong	JJ	B-NP
O	1581	1592	biochemical	biochemical	JJ	I-NP
O	1593	1596	and	and	CC	I-NP
O	1597	1604	genetic	genetic	JJ	I-NP
O	1605	1613	evidence	evidence	NN	I-NP
O	1614	1616	of	of	IN	B-PP
O	1617	1618	a	a	DT	B-NP
O	1619	1626	central	central	JJ	I-NP
O	1627	1631	role	role	NN	I-NP
O	1632	1635	for	for	IN	B-PP
O	1636	1647	alpha2beta1	alpha2beta1	NN	B-NP
O	1648	1656	integrin	integrin	NN	I-NP
O	1657	1659	in	in	IN	B-PP
O	1660	1672	experimental	experimental	JJ	B-NP
O	1673	1676	and	and	CC	I-NP
O	1677	1690	developmental	developmental	JJ	I-NP
O	1691	1703	angiogenesis	angiogenesis	NN	I-NP
O	1703	1704	.	.	.	O

